Safety of Intravenous Edaravone in Clinical Practice
Muscle & Nerve · 2026
DOI: 10.1002/mus.70038 ↗Kurz gefasst
Fachartikel in der Zeitschrift Muscle & Nerve, 2026. Verfasst von Angela Genge und 1 weiteren Autor:innen. Beteiligte Einrichtung: Montreal Neurological Institute and Hospital, Montreal, Canada. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Antipyrine, Free Radical Scavengers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Mitsubishi Tanabe Pharma America, Inc..
Abstract (Originalsprache)
This article summarizes the post‐marketing pharmacovigilance safety data of intravenous (IV) edaravone during the 1‐ and 3‐year periods following its launch for amyotrophic lateral sclerosis (ALS) in the United States. The most frequently reported adverse events (AEs) and serious AEs (SAEs) included those consistent with ALS disease progression, such as fatigue and muscular weakness, and were not qualitatively different from those reported in previous ALS trials. There were AEs and SAEs associated with IV administration, such as administration site reactions, and five non‐fatal anaphylaxis SAEs were reported. No new safety signals were identified, and IV edaravone continues to demonstrate a favorable safety profile. These insights are especially useful as treatment transitions to edaravone oral suspension, which avoids IV‐related complications. These findings underscore the importance of ongoing clinical safety assessments in informing ALS treatment decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Montreal Neurological Institute and Hospital, Montreal, Canada.
- Tanabe Pharma America, Inc., Jersey City, New Jersey, USA.
ORCID-Profile: Stephen Apple
Förderung
- Mitsubishi Tanabe Pharma America, Inc.
Zitieren
APA
Genge, A., & Apple, S. (2026). Safety of Intravenous Edaravone in Clinical Practice. Muscle & Nerve. https://doi.org/10.1002/mus.70038
Vancouver
Genge A, Apple S. Safety of Intravenous Edaravone in Clinical Practice. Muscle & Nerve. 2026. doi:10.1002/mus.70038
BibTeX
@article{Genge2026,
author = {Genge, Angela and Apple, Stephen},
title = {Safety of Intravenous Edaravone in Clinical Practice},
journal = {Muscle & Nerve},
year = {2026},
doi = {10.1002/mus.70038}
}
EUVIMED